Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial

• 主要な著者: Diane E. Milenic (著者), Kwamena E. Baidoo (著者), Martin W. Brechbiel (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2015-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The first-in-human phase 1 clinical radioimmunotherapy (RIT) trial with 212Pb-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane-trastuzumab (212Pb-TCMC-trastuzumab) was completed in October 2014 as a joint effort at the University of Alabama (UAB) and the University of California Sa...